Latest Insider Transactions at Zymergen Inc. (ZY)
This section provides a real-time view of insider transactions for Zymergen Inc. (ZY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zymergen Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zymergen Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 06
2021
|
Aaron Kimball Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+1.16%
|
$36,000
$4.47 P/Share
|
Aug 06
2021
|
Sandra E Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,330
+26.04%
|
-
|
Apr 26
2021
|
Svf Excaliber (Cayman) LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
26,614,219
+50.0%
|
-
|
Apr 26
2021
|
Matthew Ocko Director |
BUY
Conversion of derivative security
|
Indirect |
7,366,635
+31.38%
|
-
|
Apr 26
2021
|
Jay T Flatley Chairman and Acting CEO |
BUY
Conversion of derivative security
|
Direct |
44,789
+50.0%
|
-
|
Apr 26
2021
|
Sandra E Peterson Director |
BUY
Conversion of derivative security
|
Direct |
44,789
+50.0%
|
-
|
Mar 05
2021
|
Zachariah Serber Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,050
-2.7%
|
$1,944,450
$29.67 P/Share
|